Pacific Biosciences (PACB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 39,007 | 37,178 | 44,645 | 38,441 | 39,766 |
| Cost of Goods | 26,369 | 24,337 | 28,079 | 22,540 | 25,082 |
| Gross Profit | 12,638 | 12,841 | 16,566 | 15,901 | 14,684 |
| Operating Expenses | 57,617 | 21,535 | 57,842 | 55,318 | 59,619 |
| Operating Income | -44,610 | -8,357 | -41,197 | -38,877 | -44,853 |
| Interest Expense | 2,110 | 1,740 | 1,740 | 1,739 | 1,738 |
| Other Income | 2,037 | 2,006 | 2,768 | 2,999 | 4,696 |
| Pre-tax Income | -44,683 | -8,091 | -40,169 | -37,617 | -41,895 |
| Income Tax | 58 | 184 | 202 | 383 | 35 |
| Net Income Continuous | -44,741 | -8,275 | -40,371 | -38,000 | -41,930 |
| Net Income | $-44,741 | $-8,275 | $-40,371 | $-38,000 | $-41,930 |
| EPS Basic Total Ops | -0.14 | -0.03 | -0.11 | -0.13 | -0.14 |
| EPS Basic Continuous Ops | -0.14 | -0.03 | -0.12 | -0.13 | -0.14 |
| EPS Diluted Total Ops | -0.14 | -0.03 | -0.11 | -0.13 | -0.14 |
| EPS Diluted Continuous Ops | -0.14 | -0.03 | -0.12 | -0.13 | -0.14 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.12 | -0.12 | -0.12 | -0.13 |
| EBITDA(a) | $-40,309 | $-4,583 | $-37,008 | $-35,398 | $-41,547 |